POSTER: ABCL-504 Population Health and Economic Benefits of Pola-R-CHP versus R-CHOP in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) in the United States
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
ABCL,cost-effectiveness,societal value,outcomes,DLBCL,polatuzumab vedotin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要